Zobrazeno 1 - 10
of 72
pro vyhledávání: '"O. Della Casa-Alberighi"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giuseppe Turchetti, Michela Silvestri, O Della Casa Alberighi, S. Gialetti, F. Pierotti, L Trieste
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f4f365cb53dd8296e2fc0a8d6489106
https://pubmed.ncbi.nlm.nih.gov/27201802
https://pubmed.ncbi.nlm.nih.gov/27201802
Autor:
Valentina Lorenzoni, L Accame, L Trieste, Joost Frenkel, Pierre Quartier, O Della Casa Alberighi, Giuseppe Turchetti, A Martini, Marco Gattorno
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6ea170b07a28931b83884b4ec20b3d
Autor:
Silvia Federici, Valentina Lorenzoni, Pierre Quartier, F. Pierotti, L Trieste, P Duong Ngoc, Giuseppe Turchetti, A Martini, L Accame, Marco Gattorno, N Cabrera Rojas, O Della Casa Alberighi
Publikováno v:
Europe PubMed Central
Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal
When a disease affects only a few individuals in each country (ultra-orphan disease), it can be very hard to establish the costs of illness (COI) and the cost-effectiveness (CE) of treatments (ultra-orphan drugs). Conventional methods for COI and CE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16fdfcba4131626488fcee68b6c02e01
https://doi.org/10.1186/1546-0096-13-s1-p186
https://doi.org/10.1186/1546-0096-13-s1-p186
Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma
Autor:
Riccardo Haupt, Aurora Castellano, Alberto Garaventa, Maria Valeria Corrias, Loredana Amoroso, Carlo Dominici, L. Calafiore, Roberto Luksch, Giulio Andrea Zanazzo, M. Podda, O. Della Casa Alberighi
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 24(5)
BACKGROUND Cure rate for subjects with refractory or relapsing metastatic neuroblastoma is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9005c0deb5852f1b3d71f52ad3de281e
https://pubmed.ncbi.nlm.nih.gov/23396605
https://pubmed.ncbi.nlm.nih.gov/23396605
Autor:
O. Della Casa-Alberighi, Flavio Fantini, Giampiero Pasero, Ettore Marubini, Gianfranco Ferraccioli, Maurizio Cutolo, Alessandro Mathieu, Francesco Priolo
Publikováno v:
Scopus-Elsevier
A prospective, open, multicentre, randomized study with a blinded radiological end-point was started in 1991. The aim of the study was to assess whether cyclosporin A (CyA) controls ongoing anatomical damage in active early rheumatoid arthritis (RA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f94245c959ca5e90588070b3a9f0a75
https://doi.org/10.1093/rheumatology/35.suppl_2.8
https://doi.org/10.1093/rheumatology/35.suppl_2.8
Publikováno v:
Clinical pharmacology and therapeutics. 93(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8a55d507f1967a3368199b0c79525f2
https://pubmed.ncbi.nlm.nih.gov/23169431
https://pubmed.ncbi.nlm.nih.gov/23169431
Publikováno v:
Clinical pharmacology and therapeutics. 92(1)
This review summarizes the present status of physiologically based pharmacokinetic (PBPK) modeling and simulation (M&S) and its application in support of pediatric drug research. We address the reasons that PBPK is suited to the current needs of pedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a111a583422f9a2b9d322d7151419e
https://pubmed.ncbi.nlm.nih.gov/23187875
https://pubmed.ncbi.nlm.nih.gov/23187875
Autor:
S. Zenoni, Yoko Tsukahara, Andrea Rossi, V. DeMolfetta, S. Tognon, Markku Leinonen, Nobuchika Ogino, O. Della Casa-Alberighi, G. Corbetta, Cheng Deng, Kaija Airas, L. Latanza, Kazuo Iwata, Satoshi Okinami, Valter Elenius, C. De Rosa, Katsuhiko Nanba, Mika Nihira, Paola Pivetti-Pezzi, W. Behrens-Baumann, H.E. Völcker, H. Krastel, Luis Fernando Mejía, G. Bragliani, Masayoshi lwaki, Hernando Camacho, R. Scorrano, Ikki Arai, Motohiro Shirakashi, E. Mayatepek, Michael F. Marmor, B. Pfau, K. Almasan, Mitsuko Sunakawa, A.G. Secchi, G. Catarinelli
Publikováno v:
Ophthalmologica. 202:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a6188dd8a287cbff2be4b4d77c9341e
https://doi.org/10.1159/000310210
https://doi.org/10.1159/000310210
Publikováno v:
Combination Treatment in Autoimmune Diseases ISBN: 9783642077043
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c7f89bea3413820ef62e02faf40532c
https://doi.org/10.1007/978-3-662-04759-0_7
https://doi.org/10.1007/978-3-662-04759-0_7
